Literature DB >> 3469178

Susceptibility of non-fermentative gram-negative bacteria to ciprofloxacin, norfloxacin, amifloxacin, pefloxacin and cefpirome.

P C Appelbaum, S K Spangler, L Sollenberger.   

Abstract

Susceptibility of 340 mainly clinically isolated Gram-negative non-fermenters to ciprofloxacin, norfloxacin, amifloxacin, pefloxacin and cefpirome was determined by agar dilution. Ciprofloxacin was most active, with MIC90s against all organisms ranging between less than 0.125 and 4 mg/l. Norfloxacin, amifloxacin and pefloxacin were active against most strains, with MIC90 ranges (mg/l) of 0.5 - 32, 0.25 - 32 and less than 0.125 - 16, respectively. Cefpirome showed less activity than the quinolones on a weight-for-weight basis with MIC90s ranging from 0.5 to greater than 64 mg/l; only fluorescent pseudomonads and Acinetobacter calcoaceticus biotypes haemolyticus, alcaligenes were uniformly susceptible to cefpirome. The broad-spectrum activity of the four quinolones suggests potential use in therapy of infections caused by non-fermenters; cefpirome should be reserved for infections caused by fluorescent pseudomonads and possibly Acinetobacter spp.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3469178     DOI: 10.1093/jac/18.6.675

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies.

Authors:  S Bajaksouzian; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

2.  Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.

Authors:  M A Visalli; S Bajaksouzian; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

3.  Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro.

Authors:  M Lecso-Bornet; J Pierre; D Sarkis-Karam; S Lubera; E Bergogne-Berezin
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

4.  Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods.

Authors:  M A Visalli; M R Jacobs; T D Moore; F A Renzi; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

Review 5.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

6.  Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem.

Authors:  S K Spangler; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

Review 7.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

8.  Oral Bioavailability and Plasma Disposition of Pefloxacin in Healthy Broiler Chickens.

Authors:  María-Aránzazu Martínez; Irma Ares; José-Luis Rodríguez; Marta Martínez; María-Rosa Martínez-Larrañaga; Gerardo Isea; Arturo Anadón
Journal:  Front Vet Sci       Date:  2017-05-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.